Effects of Pain Scrambler Therapy for the Alterations of Cerebral Blood

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-07-01

Study Completion Date

2020-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prevalence of chronic pain has been shown to be high after thermal injury. Post-burn neuropathic pain causes chronic disabilities that is often difficult to treat effectively. Pain Scrambler therapy is a patient-specific electrocutaneous nerve stimulation device. To study changes in the pain network associated with neuropathic pain, magnetic resonance imaging(MRI) was used to evaluate cerebral blood volume(CBV) in patients who had been injuried by burn. Participants (N=40, experimental 20 and control group 20) comprised patients with neuropathic pain after thermal injury. The subjects complained of severe neuropathic pain that was rated at least 5 on the visual analogue scale (VAS), despite treatments with gabapentin medication and other physical modalities. Each Scrambler therapy with the MC5-A Calmare® therapy device (Competitive Technologies, Inc. Fairfield, USA ) was performed for 40 min daily (Monday through Friday) for 10 consecutive days. The stimulus was increased to the maximum intensity bearable by the individual patient without causing any additional pain or discomfort. The intensity of neuropathic pain was measured using the visual analogue scale(VAS). Depressive mood was assessed using the Beck Depression Scale. Voxel-wise comparisons of relative CBV maps were made between before scrambler therapy and after 10 scrambler therapy sessions over the entire brain volume. The relationship between individual participant CBV(measured in voxels), BDS and VAS score was also examined. We observed decreased in the cerebral pain network of patients with burn injury. Scrambler therapy is a non-invasive, non-medicinal modality that significantly reduced burn-associated neuropathic pain. Scrambler therapy should be considered as a treatment option for burn survivors with severe neuropathic pain.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Brain Network Stimulation for Chronic Low Back Pain.

NCT06902233

Chronic Low Back Pain (CLBP)

RECRUITING NA

Pain Relief by Platelet-rich Plasma (PRP) Treatment

NCT01749839

Sciatica

UNKNOWN

Blue Light Device for Pain Therapy

NCT01528332

Low Back Pain Low Back Pain, Recurrent Musculoskeletal Pain +1 more

COMPLETED PHASE3

Enhancing Acupuncture Treatment Effect Through Non-invasive Neuromodulation

NCT03716830

Chronic Pain

COMPLETED NA

Back Pain Response to Different Acupuncture Methods

NCT01598974

Lower Back Pain

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The groups (scrambler therapy and sham therapy) were randomly assigned. All subjects were recruited in scrambler thrapy and sham stimulation. Main study outcomes included group differences in CBV changed and the the relationship between CBV changes and neuropathic pain intensity. These analyses were performed using the same framework of the general linear model, which was repeatedly applied to each voxel with the same coordinates.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain, Neuropathic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

scarmbler treatment group

Each Scrambler therapy with the MC5-A Calmare® therapy device (Competitive Technologies, Inc. Fairfield, USA ) was performed for 40 min daily (Monday through Friday) for 10 consecutive days. The experimental participants were received scarmbler therapy 10 times for 2 weeks. The stimulus was increased to the maximum intensity bearable by the individual patient without causing any additional pain or discomfort.

Group Type EXPERIMENTAL

scarmbler therapy

Intervention Type DEVICE

Scrambler therapy is a patient-specific electrocutaneous nerve stimulation device.

sham treatment group

conservative management without scarmbler therapy

Group Type SHAM_COMPARATOR

scarmbler therapy

Intervention Type DEVICE

Scrambler therapy is a patient-specific electrocutaneous nerve stimulation device.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

scarmbler therapy

Scrambler therapy is a patient-specific electrocutaneous nerve stimulation device.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Burn patients
* severe neuropatic pain rated at least 5 on the 10-point numerical rating scale (NRS)

Exclusion Criteria

* cardiac arrest history
* history of neurologi disease or brain surgery
* unstable heart disease or presence of a cardiac pacemaker
* pain resulting from other causes like as neuromuscular diseases
* psychiatric disorder
* diabetes mellitus
* abnormal renal function
* contraindication for MRI, or pregnancy.

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes